Institute of Biomedicine, Integrative Physiology and Pharmacy, University of Turku, FI-20014 Turku, Finland.
Aurlide Ltd., FI-21420 Lieto, Finland.
J Chem Inf Model. 2022 Feb 28;62(4):1100-1112. doi: 10.1021/acs.jcim.1c01145. Epub 2022 Feb 8.
Molecular docking is a key in silico method used routinely in modern drug discovery projects. Although docking provides high-quality ligand binding predictions, it regularly fails to separate the active compounds from the inactive ones. In negative image-based rescoring (R-NiB), the shape/electrostatic potential (ESP) of docking poses is compared to the negative image of the protein's ligand binding cavity. While R-NiB often improves the docking yield considerably, the cavity-based models do not reach their full potential without expert editing. Accordingly, a greedy search-driven methodology, brute force negative image-based optimization (BR-NiB), is presented for optimizing the models via iterative editing and benchmarking. Thorough and unbiased training, testing and stringent validation with a multitude of drug targets, and alternative docking software show that BR-NiB ensures excellent docking efficacy. BR-NiB can be considered as a new type of shape-focused pharmacophore modeling, where the optimized models contain only the most vital cavity information needed for effectively filtering docked actives from the inactive or decoy compounds. Finally, the BR-NiB code for performing the automated optimization is provided free-of-charge under MIT license via GitHub (https://github.com/jvlehtonen/brutenib) for boosting the success rates of docking-based virtual screening campaigns.
分子对接是现代药物发现项目中常用的一种关键的计算方法。尽管对接可以提供高质量的配体结合预测,但它经常无法将活性化合物与非活性化合物区分开来。在基于负像的重评分(R-NiB)中,对接构象的形状/静电势(ESP)与蛋白质配体结合腔的负像进行比较。虽然 R-NiB 通常可以大大提高对接产率,但如果没有专家编辑,基于腔的模型并不能充分发挥其潜力。因此,提出了一种贪婪搜索驱动的方法,即蛮力负像优化(BR-NiB),通过迭代编辑和基准测试来优化模型。通过对多种药物靶标和替代对接软件进行彻底和无偏的训练、测试和严格验证,BR-NiB 确保了出色的对接效果。BR-NiB 可以被认为是一种新型的基于形状的药效团建模方法,其中优化的模型仅包含从非活性或诱饵化合物中有效筛选出活性化合物所需的最关键的腔信息。最后,BR-NiB 的代码可免费在 MIT 许可证下通过 GitHub(https://github.com/jvlehtonen/brutenib)获得,以提高基于对接的虚拟筛选活动的成功率。